rs2160079

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_006329.4(FBLN5):​c.380-12989T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.86 in 152,206 control chromosomes in the GnomAD database, including 56,841 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.86 ( 56841 hom., cov: 31)

Consequence

FBLN5
NM_006329.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.223

Publications

5 publications found
Variant links:
Genes affected
FBLN5 (HGNC:3602): (fibulin 5) The protein encoded by this gene is a secreted, extracellular matrix protein containing an Arg-Gly-Asp (RGD) motif and calcium-binding EGF-like domains. It promotes adhesion of endothelial cells through interaction of integrins and the RGD motif. It is prominently expressed in developing arteries but less so in adult vessels. However, its expression is reinduced in balloon-injured vessels and atherosclerotic lesions, notably in intimal vascular smooth muscle cells and endothelial cells. Therefore, the protein encoded by this gene may play a role in vascular development and remodeling. Defects in this gene are a cause of autosomal dominant cutis laxa, autosomal recessive cutis laxa type I (CL type I), and age-related macular degeneration type 3 (ARMD3). [provided by RefSeq, Jul 2008]
FBLN5 Gene-Disease associations (from GenCC):
  • cutis laxa, autosomal dominant 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp
  • cutis laxa, autosomal recessive, type 1A
    Inheritance: SD, AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • Charcot-Marie-Tooth disease, demyelinating, IIA 1H
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • demyelinating hereditary motor and sensory neuropathy
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • macular degeneration, age-related, 3
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • autosomal dominant cutis laxa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary sensorimotor neuropathy with hyperelastic skin
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive cutis laxa type 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.915 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FBLN5NM_006329.4 linkc.380-12989T>G intron_variant Intron 4 of 10 ENST00000342058.9 NP_006320.2 Q9UBX5A0A024R6G3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FBLN5ENST00000342058.9 linkc.380-12989T>G intron_variant Intron 4 of 10 1 NM_006329.4 ENSP00000345008.4 Q9UBX5

Frequencies

GnomAD3 genomes
AF:
0.860
AC:
130775
AN:
152088
Hom.:
56810
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.744
Gnomad AMI
AF:
0.967
Gnomad AMR
AF:
0.927
Gnomad ASJ
AF:
0.870
Gnomad EAS
AF:
0.762
Gnomad SAS
AF:
0.771
Gnomad FIN
AF:
0.929
Gnomad MID
AF:
0.873
Gnomad NFE
AF:
0.915
Gnomad OTH
AF:
0.886
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.860
AC:
130870
AN:
152206
Hom.:
56841
Cov.:
31
AF XY:
0.859
AC XY:
63920
AN XY:
74390
show subpopulations
African (AFR)
AF:
0.745
AC:
30909
AN:
41510
American (AMR)
AF:
0.927
AC:
14179
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.870
AC:
3019
AN:
3472
East Asian (EAS)
AF:
0.762
AC:
3945
AN:
5174
South Asian (SAS)
AF:
0.771
AC:
3722
AN:
4826
European-Finnish (FIN)
AF:
0.929
AC:
9838
AN:
10592
Middle Eastern (MID)
AF:
0.871
AC:
256
AN:
294
European-Non Finnish (NFE)
AF:
0.915
AC:
62256
AN:
68024
Other (OTH)
AF:
0.883
AC:
1864
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
885
1771
2656
3542
4427
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
890
1780
2670
3560
4450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.892
Hom.:
44949
Bravo
AF:
0.855
Asia WGS
AF:
0.762
AC:
2652
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.97
CADD
Benign
4.7
DANN
Benign
0.65
PhyloP100
0.22
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2160079; hg19: chr14-92374405; API